David is a registered patent attorney whose practice focuses on the strategic development of worldwide intellectual property portfolios, with a particular focus on preparing and prosecuting patent and trademark applications in the areas of biotechnology, pharmaceuticals and medical devices.
He has experience performing intellectual property due diligence, including prior art searching, and patentability, freedom-to-operate, and non-infringement analyses. David also has experience counseling clients on the Hatch-Waxman Act and is closely following developments involving biosimilars under the Biologics Price Competition and Innovation Act.
He recently taught Intellectual Property and Patent Law for Researchers, an elective course for the Online Masters in Pharmacology and Toxicology at Michigan State University.
Prior to joining MBBP, David worked as a patent attorney and associate at Greenberg Traurig, LLP, and as a patent agent at Myriad Genetics, Inc. David received his J.D. cum laude from J. Reuben Clark Law School, and received his B.S. summa cum laude in Pharmacology from SUNY at Stony Brook. David received his M.S. cum laude in Biotechnology from Johns Hopkins University in May 2012.
J. Reuben Clark Law School
SUNY at Stony Brook
Johns Hopkins University